If you are looking for some ASX 200 shares to add to your retirement portfolio, then it could be worth looking at the two listed below.
Both of these ASX retirement shares have recently been named as buys by analysts and tipped to climb meaningfully higher from current levels. Here's what you need to know about them:
Coles Group Ltd (ASX: COL)
The first ASX 200 retirement share to consider buying is Coles. It is of course one of Australia's big two supermarket operators.
While its performance in FY 2023 was disappointing, analysts at Citi remain positive. Particularly given its defensive qualities and the ~$140 million "Witron benefits coming through in FY25/FY26."
Another positive is the attractive yields on offer with the company's shares. Citi is forecasting fully franked dividends per share of 61 cents in FY 2024 and 68 cents in FY 2025. This represents yields of 3.8% and 4.2%, respectively.
Citi has a buy rating and a $18.30 price target on its shares.
CSL Limited (ASX: CSL)
Another ASX 200 share that could be a good option for a retirement portfolio is CSL.
It is one of the world's leading biotherapeutics companies and the owner of a collection of industry-leading therapies. This includes important therapies such as Privigen, Hizentra, Idelvion, and Afstyla.
The company is also adding to its portfolio through acquisitions and its research and development (R&D) activities. The latter sees the company reinvest in the region of 12% of its sales into these activities each year. This means it has an R&D pipeline containing some potentially lucrative and life-saving therapies and vaccines to drive its future growth.
Morgans is positive on the company and has an add rating and $328.20 price target on its shares.
